P/B
15,5
HeartFlow Inc is a commercial-stage medical technology company that has pioneered the use of software and AI to deliver a non-invasive solution for diagnosing and managing coronary artery disease CAD. The company operates and manages its business as one reportable and operating segment, which is the business of non-invasive coronary artery disease detection solutions. Geographically, it operates in United States, United Kingdom, Japan, and Rest of Europe, of which it derives maximum revenue from United States.
HeartFlow Inc is a commercial-stage medical technology company that has pioneered the use of software and AI to deliver a non-invasive solution for diagnosing and managing coronary artery disease CAD. The company operates and manages its business as one reportable and operating segment, which is the business of non-invasive coronary artery disease detection solutions. Geographically, it operates in United States, United Kingdom, Japan, and Rest of Europe, of which it derives maximum revenue from United States.
$4.3B
Market Cap • 9/30/2026
2007
(19 years)
Founded
2025
(1 year ago)
IPO
NASDAQ
Listing Exchange
United States
Country
Valuation
P/S
20,4
P/EBITDA
—
P/OCF
—
P/FCF
—
P/E
—
BVPS
3,2
EPS
—
Market Cap
Market Cap
4,3B
EV
4,2B
EV/Revenue
19,8
EV/EBITDA
-55,9
EV/EBIT
-52,2
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
-8%
Total Yield
-8%
Payout
0%
Retained Earnings
-1,1B
Profitability
Gross Margin
80,1%
EBITDA Margin
—
EBIT Margin
—
Net Margin
—
D&A/EBITDA
0%
R&D/Revenue
39,5%
Capex/Revenue
3,3%
Capex/D&A
130,7%
Capex/OCF
-13,3%
SBC/OCF
—
% PPE
7,2%
% Goodwill
0%
ROE
—
ROIC
—
Leverage
N.D./EBITDA
1,8
Debt/Equity
0%
Current Ratio
5,1
Quick Ratio
4,7
Interest Coverage
—
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!